Last updated: August 17, 2026

Osteoarthritis (OA) is a degenerative joint disease that affects millions of people worldwide. It is characterized by the breakdown of cartilage, the tissue that cushions the ends of bones, leading to pain, stiffness, and reduced mobility. Knee OA is the most common type of OA, affecting over 10% of the population over the age of 60.

The Potential of Stem Cells in Treating Knee Osteoarthritis

Stem cells are unspecialized cells that have the ability to develop into various types of specialized cells, including cartilage cells. This makes them a promising potential treatment for OA, as they could be used to regenerate damaged cartilage and restore joint function.

Exploring the Role of Stem Cells in Knee Osteoarthritis Regeneration

Several studies have investigated the use of stem cells to treat knee OA. In one study, researchers injected mesenchymal stem cells (MSCs) into the knee joints of patients with OA. The results showed that the MSCs were able to differentiate into cartilage cells and reduce pain and stiffness. Another study found that adipose-derived stem cells (ASCs) were also effective in reducing pain and improving function in patients with knee OA.

These studies provide promising evidence for the potential of stem cells in treating knee OA. However, further research is needed to determine the long-term efficacy and safety of this approach. If successful, stem cell therapy could offer a new and effective treatment option for patients with this debilitating condition.

Scientific case review

Scientific Case Review

Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?

Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.

  • Review of the information you provide
  • Relevant research and clinical program information
  • A clear response focused on your situation
What happens next? Send your question, receive a focused scientific review, and get a clear response about research and clinical programs relevant to your situation.
Your scientific review will be prepared by Dr. Helen Melnik, PhD , who has more than 25 years of experience in stem cell research and international clinical programs.

No obligation. Your question will be reviewed confidentially.

Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.

Categories: StammzellbehandlungStem cell in EuropeStem Cell Marketstem cell researchstem cell therapiesStem Cell therapyStem Cell Therapy & Clinical ResearchStem Cell Treatmentstem cellsStem Cells Clinical Trialsstem cells therapystem cells treatmentstem cells warningtraitement des cellules souchestratamiento con células madreUse of Stem Cells in  CancerUse of Stem Cells in  Heart DiseaseUse of Stem Cells in  Kidney DiseaseUse of Stem Cells in  Liver DiseaseUse of Stem Cells in  Lung DiseaseUse of Stem Cells in  Multiple SclerosisUse of Stem Cells in StrokeVisiting Clinical Research CoordinatorWhat is "fetal stem cells products"?What is difference in quality of stem cell therapy?

NBScience

contract research organization

WhatsApp